Edward Nash
Stock Analyst at Canaccord Genuity
(4.90)
# 264
Out of 4,453 analysts
376
Total ratings
52.5%
Success rate
28.5%
Average return
Main Sectors:
Stocks Rated by Edward Nash
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APGE Apogee Therapeutics | Downgraded: Hold | $130 → $135 | $132.68 | +1.83% | 15 | Jun 23, 2026 | |
| CNTB Connect Biopharma Holdings | Maintained: Buy | $6 | $2.07 | +189.86% | 2 | Jun 17, 2026 | |
| TVTX Travere Therapeutics | Maintained: Buy | $56 | $59.03 | -5.13% | 37 | Jun 2, 2026 | |
| KYMR Kymera Therapeutics | Maintained: Buy | $106 | $116.46 | -8.98% | 3 | Jun 1, 2026 | |
| CORT Corcept Therapeutics | Reiterated: Buy | $110 → $135 | $84.75 | +59.29% | 53 | May 28, 2026 | |
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $5 | $0.7423 | +573.58% | 16 | May 20, 2026 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Reiterated: Buy | $11.39 | $1.49 | +664.41% | 24 | May 19, 2026 | |
| VERU Veru Inc. | Rated: Buy | $25 | $2.94 | +750.34% | 3 | May 14, 2026 | |
| PLRX Pliant Therapeutics | Maintained: Hold | $3 | $1.13 | +165.49% | 15 | May 12, 2026 | |
| SGMT Sagimet Biosciences | Maintained: Buy | $49 | $6.86 | +614.29% | 11 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $34.09 | +81.87% | 11 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $48.25 | +109.33% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $587 → $578 | $513.79 | +12.50% | 40 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 | $36.99 | +189.27% | 7 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $62 → $64 | $56.89 | +12.50% | 3 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $3.50 | +471.43% | 14 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $5.03 | n/a | 8 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $5.00 | n/a | 6 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $15 | $0.5735 | n/a | 15 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $1 | $0.0001 | n/a | 2 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $4.64 | n/a | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $11 | $31.42 | n/a | 7 | Aug 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 | $1.86 | n/a | 1 | Jun 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $39 | $5.75 | n/a | 9 | May 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $176 | $16.02 | n/a | 15 | Feb 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 → $64 | $49.10 | n/a | 2 | Feb 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $126 → $117 | $57.35 | n/a | 14 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $71 | $29.25 | n/a | 11 | Jan 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $156 | $59.68 | n/a | 1 | Sep 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $132 | $888.65 | n/a | 1 | Sep 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $22 → $4 | $14.18 | n/a | 3 | Jun 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $11.75 | n/a | 1 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $23 | $5.56 | n/a | 2 | May 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $0.0001 | n/a | 1 | Sep 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $2 | $0.001 | n/a | 2 | May 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $6 | $3.50 | n/a | 8 | May 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $15.07 | n/a | 3 | Mar 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $11 | $3.84 | n/a | 3 | Sep 4, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $12.32 | n/a | 2 | May 3, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $23.72 | n/a | 1 | Jan 28, 2013 |
Apogee Therapeutics
Jun 23, 2026
Downgraded: Hold
Price Target: $130 → $135
Current: $132.68
Upside: +1.83%
Connect Biopharma Holdings
Jun 17, 2026
Maintained: Buy
Price Target: $6
Current: $2.07
Upside: +189.86%
Travere Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: $56
Current: $59.03
Upside: -5.13%
Kymera Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $106
Current: $116.46
Upside: -8.98%
Corcept Therapeutics
May 28, 2026
Reiterated: Buy
Price Target: $110 → $135
Current: $84.75
Upside: +59.29%
Rani Therapeutics Holdings
May 20, 2026
Reiterated: Buy
Price Target: $5
Current: $0.7423
Upside: +573.58%
Cardiol Therapeutics Inc.
May 19, 2026
Reiterated: Buy
Price Target: $11.39
Current: $1.49
Upside: +664.41%
Veru Inc.
May 14, 2026
Rated: Buy
Price Target: $25
Current: $2.94
Upside: +750.34%
Pliant Therapeutics
May 12, 2026
Maintained: Hold
Price Target: $3
Current: $1.13
Upside: +165.49%
Sagimet Biosciences
May 12, 2026
Maintained: Buy
Price Target: $49
Current: $6.86
Upside: +614.29%
May 8, 2026
Maintained: Buy
Price Target: $62
Current: $34.09
Upside: +81.87%
May 8, 2026
Reiterated: Buy
Price Target: $101
Current: $48.25
Upside: +109.33%
May 7, 2026
Maintained: Buy
Price Target: $587 → $578
Current: $513.79
Upside: +12.50%
May 4, 2026
Reiterated: Buy
Price Target: $107
Current: $36.99
Upside: +189.27%
Apr 29, 2026
Rated: Buy
Price Target: $62 → $64
Current: $56.89
Upside: +12.50%
Apr 2, 2026
Maintained: Buy
Price Target: $20
Current: $3.50
Upside: +471.43%
Oct 2, 2024
Maintained: Buy
Price Target: $9
Current: $5.03
Upside: n/a
May 17, 2023
Maintained: Hold
Price Target: $2
Current: $5.00
Upside: n/a
Aug 8, 2022
Downgraded: Hold
Price Target: $5 → $15
Current: $0.5735
Upside: n/a
Jul 29, 2022
Downgraded: Hold
Price Target: $12 → $1
Current: $0.0001
Upside: n/a
May 18, 2021
Maintained: Buy
Price Target: $25
Current: $4.64
Upside: n/a
Aug 9, 2019
Maintained: Buy
Price Target: $9 → $11
Current: $31.42
Upside: n/a
Jun 5, 2019
Downgraded: Hold
Price Target: $5
Current: $1.86
Upside: n/a
May 20, 2019
Maintained: Buy
Price Target: $60 → $39
Current: $5.75
Upside: n/a
Feb 27, 2019
Reiterated: Buy
Price Target: $176
Current: $16.02
Upside: n/a
Feb 26, 2019
Maintained: Buy
Price Target: $48 → $64
Current: $49.10
Upside: n/a
Feb 25, 2019
Maintained: Buy
Price Target: $126 → $117
Current: $57.35
Upside: n/a
Jan 23, 2019
Maintained: Buy
Price Target: $54 → $71
Current: $29.25
Upside: n/a
Sep 24, 2018
Maintained: Buy
Price Target: $156
Current: $59.68
Upside: n/a
Sep 17, 2018
Maintained: Buy
Price Target: $132
Current: $888.65
Upside: n/a
Jun 27, 2018
Downgraded: Hold
Price Target: $22 → $4
Current: $14.18
Upside: n/a
Jun 25, 2018
Initiated Coverage: Buy
Price Target: $26
Current: $11.75
Upside: n/a
May 16, 2018
Maintained: Buy
Price Target: $26 → $23
Current: $5.56
Upside: n/a
Sep 18, 2017
Maintained: Buy
Price Target: $24
Current: $0.0001
Upside: n/a
May 16, 2017
Reiterated: Hold
Price Target: $1 → $2
Current: $0.001
Upside: n/a
May 5, 2017
Reiterated: Hold
Price Target: $3 → $6
Current: $3.50
Upside: n/a
Mar 7, 2017
Reiterated: Hold
Price Target: $9
Current: $15.07
Upside: n/a
Sep 4, 2014
Downgraded: Hold
Price Target: $14 → $11
Current: $3.84
Upside: n/a
May 3, 2013
Downgraded: Sell
Price Target: n/a
Current: $12.32
Upside: n/a
Jan 28, 2013
Initiated Coverage: Buy
Price Target: n/a
Current: $23.72
Upside: n/a